Denise van der Graaff
13 works · 701 citations · h-index 6
Top works
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats
- Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD
- Systemic lupus erythematosus presenting as non-resolving pneumonia: a case report
- The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis
- Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer
- Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
- Portal Hypertension in NASH: Is It Different from Other Aetiologies?
- SAT-117-YI Ultrastructural assessment of liver sinusoidal endothelial cell capillarisation in metabolic-dysfunction associated steatotic liver disease and its modulation by lanifibranor
- THU-258-YI Altered liver vascular biology occurring in early stages of metabolic dysfunction-associated steatotic liver disease is significantly improved by the pan-peroxisome proliferatoractivated receptoragonist lanifibranor, associating with improved liver histology
- Treatment with the endothelin receptor inhibitor bosentan alleviates the NAFLD-associated increased intrahepatic vascular resistance and reduces steatosis and liver damage in a rat model of early NAFLD
- Tu1656 THE ANGIOTENSIN RECEPTOR BLOCKER VALSARTAN ALLEVIATES THE INCREASED INTRAHEPATIC VASCULAR RESISTANCE AND DECREASES LIVER DAMAGE IN A RAT MODEL OF SEVERE STEATOSIS
- Hyperreactivity to vasoconstrictors in a rat model of nonalcoholic fatty liver disease